<DOC>
	<DOCNO>NCT00131456</DOCNO>
	<brief_summary>The purpose study determine Venlafaxine Extended Release ( Ven-XR ) effective treat individual marijuana addiction depression .</brief_summary>
	<brief_title>Free Venlafaxine Treatment Marijuana Addiction Depression - 1</brief_title>
	<detailed_description>Given depression marijuana addiction often occur together , medication treat individual diagnose condition may effective . The purpose study determine effectiveness Ven-XR treating individual diagnose depression marijuana addiction . During twelve-week , double-blind , placebo-controlled study , study visit occur twice week . During study visit , participant receive either placebo medication provide urine sample drug screening . Blood test collect month woman must take pregnancy test month . Throughout study , participant receive individualize psychotherapy session . At study visit , participant give $ 5 cover transportation cost .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>Meets criteria current marijuana addiction report marijuana primary drug abuse Currently meet criterion major depression dysthymic disorder receive score great equal 12 Hamilton Depression Inventory Clinically depress least 3 month period active marijuana use Women childbearing age include provide pregnant , base result blood pregnancy do time screen agree use method contraception proven efficacy become pregnant study . To confirm , blood pregnancy test repeat monthly . Women provide full explanation potential danger pregnancy study . If woman become pregnant , study medication discontinue . Meets criteria past manic psychotic disorder , unless substancerelated History seizure disorder Individuals chronic organic mental syndrome Any significant risk suicide base current assessment history attempt History allergic reaction either Venlafaxine VenXR Unstable physical disorder might make participation hazardous , uncontrolled hypertension tachycardia ( SBP &gt; 150 , DBP &gt; 90 , sit quietly HR &gt; 100 ) , acute hepatitis ( patient chronic mildly elevated transaminase level ( &lt; 2x upper limit normal acceptable ) unstable diabetes History failure respond previous adequate trial Venlafaxine least 300 mg. least 6week period Physical dependence drug ( exclude nicotine ) would require medical detoxification Currently prescribe psychotropic medication another physician ( last 3 week ) , except acute treatment insomnia . Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>cannabis dependence</keyword>
	<keyword>depression</keyword>
	<keyword>treatment</keyword>
	<keyword>venlafaxine</keyword>
</DOC>